Lv1
10 积分 2024-02-14 加入
AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial
2个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
9个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
9个月前
已完结
皖公网安备34019202002308
